Eur J Hosp Pharm 19:507-509 doi:10.1136/ejhpharm-2012-000202
  • Cover story

Knowing when evidence is trustworthy

Editor's Choice
  1. Scott A Strassels2
  1. 1Pain Research and Nuffield Division of Anaesthetics, University of Oxford, The Churchill Hospital, Oxford, UK
  2. 2Division of Health Outcomes and Pharmacy Practice, College of Pharmacy, University of Texas at Austin, Austin, Texas, USA
  1. Correspondence to Dr R A Moore, Pain Research and Nuffield Division of Anaesthetics, Nuffield Department of Clinical Neurosciences, University of Oxford, The Churchill Hospital, Oxford OX3 7LE, UK; andrew.moore{at}
  • Received 24 September 2012
  • Accepted 28 September 2012
  • Published Online First 26 October 2012


Evidence-based medicine is often seen as something dry, formal, and statistical, often used to justify a proscriptive approach to medicine. A more attractive approach is to use our understanding of those aspects of studies that can mislead us to identify the evidence we can trust. Evidence can, and probably should, be based on patient-centred outcomes of importance to clinical practice. The particular issues differ somewhat between clinical trials, observational studies, adverse events, diagnosis, and health economics. Here we explore some of important criteria relating to evidence from randomised trials, either alone or in meta-analyses.

EJHP blog

Analysis and discussion of the latest news, research findings and policy developments in hospital pharmacy.

Visit the blog >>

Free Sample

This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of EJHP.

View free sample issue >>

Email alerts

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article